Corporate partnership CR-CP Life Science Fund led the cancer detection test developer’s series C round, which took its total funding to $120m.

GV participated in a series C round for the online flexible staffing portal at a valuation of $560m, hiking its overall funding to $100m.

Softbank-backed Tridge, a digital trading platform dedicated to the agriculture sector, has secured series C funding to scale up its fulfilment service and expand its global presence.

Munich Re and Microsoft helped CO2-to-chemicals technology provider Twelve raise $57m while Eli Lilly and Kaiser Permanente-backed CRO dMed-Clinipac secured $50m.

The precision oncology platform is based on research by Duke and Hubrecht Institute faculty and the cash will fund technology development and clinical studies.

GV contributed to the precision oncology platform developer's series A round, which will fund technology development and clinical studies.

Novo and Sanofi Ventures both participated in a series A round for the neurodegenrative disease drug developer, which is led by EIRs at Novo Seeds.

The musculoskeletal healthcare provider has added cash from Intermountain Healthcare, Ascension Ventures and Echo Health Ventures to a round now surpassing $50m.

VIB and V-Bio Ventures have both participated in a series A round for Muna Therapeutics, the result of a merger of two recent spinouts.

The M12-backed workforce management software developer has increased its overall funding to $115m through a series C round led by SoftBank.